Use of Clesrovimab for Prevention of Severe Respiratory Syncytial Virus– Associated Lower Respiratory Tract Infections in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2025.

Saved in:
Bibliographic Details
Title: Use of Clesrovimab for Prevention of Severe Respiratory Syncytial Virus– Associated Lower Respiratory Tract Infections in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2025.
Authors: Moulia, Danielle L.1 media@cdc.gov, Link-Gelles, Ruth1, Chu, Helen Y.2, Jamieson, Denise3, Brooks, Oliver4, Meyer, Sarah5, Weintraub, Eric S.5, Shay, David K.5, Prill, Mila M.1, Thomas, Ebony S.6, Hutton, David7, Ortega-Sanchez, Ismael R.1, MacNeil, Adam1, McMorrow, Meredith L.1, Jones, Jefferson M.1
Source: MMWR: Morbidity & Mortality Weekly Report. 8/28/2025, Vol. 74 Issue 32, p508-515. 8p.
Database: Academic Search Ultimate
Description
ISSN:01492195
DOI:10.15585/mmwr.mm7432a3